Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mesa Laboratories announced its acquisition of Gyros Protein Technologies, a differentiated leader in biopharmaceutical development solutions. The transaction combines Mesa's operational excellence with Gyros' innovative product portfolio and global talent, expected to drive organic growth and deliver accretion to Mesa across multiple financial metrics.
investor_presentation
39 Pages
Van Lanschot Kempen
investor_presentation
Apergy